12-LEAD RESTING ELECTROCARDIOGRAPH, MODELS CP100 & CP200

K050074 · Welch Allyn, Inc. · DPS · Mar 22, 2005 · Cardiovascular

Device Facts

Record IDK050074
Device Name12-LEAD RESTING ELECTROCARDIOGRAPH, MODELS CP100 & CP200
ApplicantWelch Allyn, Inc.
Product CodeDPS · Cardiovascular
Decision DateMar 22, 2005
DecisionSESE
Submission TypeAbbreviated
Regulation21 CFR 870.2340
Device ClassClass 2
AttributesPediatric

Intended Use

The Welch Allyn Printing Electrocardiography and Spirometry Products (Subject Devices) are intended for use by trained operators in health facilities. The subject Devices will provide the following diagnostic functions: Acquiring, viewing, storing and printing ECG waveforms patients using ECG Front End modules and associated accessories that provide signal acquisition for up to twelve (12) leads of patient ECG waveforms through surface electrodes adhered to the body. Using optional algorithms to generate measurements, data presentations, graphical presentations and interpretive statements on an advisory basis for patients of sixteen (16) years of age and above. These are presented for review and interpretation by the clinician based upon knowledge of the patient, the results of the physical examination, the ECG tracings, and other clinical findings. Using the optional Spirometry module and associated accessories to acquire, view, store and print measures and waveforms of pulmonary function including, but not limited to, maximal volume and flow of air that can be moved in and out of a patient's lungs. These measures are used in the diagnosis and monitoring of lung diseases and interventions for the treatment of certain lung diseases. The spirometer should only be used with patients able to understand the instructions for performing the test, such as with children greater than three (3) years of age.

Device Story

CP 100 and CP 200 are multi-channel electrocardiographs with optional spirometry modules. Devices acquire ECG signals via surface electrodes (up to 12 leads) and pulmonary airflow data via spirometry accessories. Inputs are processed to generate waveforms, measurements, and interpretive statements. Operated by trained clinicians in health facilities; data is viewed on-screen and printed on thermal paper. ECG algorithms provide advisory interpretive statements for patients 16+; spirometry modules measure lung volume and flow for diagnosis/monitoring of lung disease. Output supports clinical decision-making by providing diagnostic data for physician review alongside physical exams and clinical findings.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Multi-channel electrocardiograph and spirometer. Features alphanumeric keyboard, thermal paper printer, and battery/AC power. ECG sensing via surface electrodes; spirometry via flow/volume sensors. Connectivity includes ECG front-end modules. Software includes optional diagnostic algorithms for ECG and pulmonary function analysis.

Indications for Use

Indicated for patients requiring ECG monitoring (age 16+) and pulmonary function testing (age 3+). ECG interpretation algorithms are for patients 16 years and older. Spirometry results are not calculated for children under 6 years. Intended for use by trained operators in health facilities.

Regulatory Classification

Identification

An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ### MAR 2 2 2005 # Welch Allyn 7AlBreviated 510(k) Prernarket Notification Welch Allyn Printing Electrocardiography and Spirometry Froducts ## 12. Premarket Notification [510(k)] Summary | Submitted By: | Welch Allyn, Inc.<br>4341 State Street Road<br>Skaneateles Falls, NY 13153-0220<br>Phone: 315-554-5289<br>Fax: 315-685-2532<br>Contact: Joshua S. Kim | |---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------| |---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------| - Electrocardiographs Common Name: CP 100 and CP 200 (including Spirometry) Trade Name: - 21 CFR 870.2340 Classification: - Predicate Device: The legally marketed medical devices to which substantially equivalent to the following: - PageWriter Trim Series Cardiograph (K031422) ● - Spirometer System (Medikro D9 Spirometer) (K971336) . - The Welch Allyn Multi-Channel Electrocardiographs, the low cost Description: CP 100 or full-featured CP200. Both feature full alphanumeric keyboards for easy and fast entry of patient demographics, userprogrammable report formats printed on patient chart size thermal paper, ECG measurement, advanced filters for optimal ECG trace quality and battery or AC operation. #### Intended Use: The Welch Allyn Printing Electrocardiography and Spirometry Products (Subject Devices) are intended for use by trained operators in health facilities. The subject Devices will provide the following diagnostic functions: {1}------------------------------------------------ # WelchAllyn Abbreviated 510(k) Premarket Notification Abbieriator Printing Electrocardiography and Spirometry Products - Acquiring, viewing, storing and printing ECG waveforms patients using ECG . Front End modules and associated accessories that provide signal acquisition for up to twelve (12) leads of patient ECG waveforms through surface electrodes adhered to the body. - Using optional algorithms to generate measurements, data presentations, . graphical presentations and interpretive statements on an advisory basis for patients of sixteen (16) years of age and above. These are presented for review and interpretation by the clinician based upon knowledge of the patient, the results of the physical examination, the ECG tracings, and other clinical findings. - Using the optional Spirometry module and associated accessories to acquire, . view, store and print measures and waveforms of pulmonary function including, but not limited to, maximal volume and flow of air that can be moved in and out of a patient's lungs. These measures are used in the diagnosis and monitoring of lung diseases and interventions for the treatment of certain lung diseases. The spirometer should only be used with patients able to understand the instructions for performing the test, such as with children greater than three (3) years of age. {2}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Image /page/2/Picture/2 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized caduceus, a symbol often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus. The seal is black and white. MAR 2 2 2005 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Welch Allyn, Inc. c/o Mr. Christopher Klaczyk Regulatory Affairs Manager 4341 State Street Road P.O. Box 220 Skaneateles Falls, NY 13153-0220 Re: K050074 K050074 Trade Name: CP 100 and CP 200 (including Spirometry) Trade Name: CP 100 and CPD 200 2340 Trade Name: 21 CFR 892.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II (two) Product Code: DPS Dated: March 8, 2005 Received: March 9, 2005 Dear Mr. Klaczyk: We have reviewed your Section 510(k) premarket notification of intent to market the device ty the indication in the supportual the dayson is substantially equivalent (for the We have reviewed your Section 5 IQC) premiated in useuivalent (for the indications referenced above and have determined the devices marked in interstate referenced above and have determined the devices marketed in interstate for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the enclosure) to legally marketed previce Amendments, or to commerce prior to May 28, 1976, the enactment date of the Medical Food, Drug, commerce prior to May 28, 1976, the enactment and of the Federal Food, Drug, devices that have been reclassified in accordance while to warder approval application (PMA). and Cosmetic Act (Act) that do not require approval of a provisions of the Act. and Cosmetic Act (Act) that do not require approval or the general ontrols of the Act. The Act. The You may, therefore, market for any and registered registrations of list You may, therefore, market the device, subject to the general ocanced registration, listing of general controls provisions of the Act Include requirements for any instranding general controls provisions of the Act Include requirements for the only of the many and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it in the can and the cases of the class to desting major regulations If your device is classified (see above) mio entirer cass in openar over device can may be subject to such additional controls. Listing major regulations affection, FDA may may be subject to such additional controls. Extraig major regalataons and and the may be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, F be found in the Code of Federal Regulations, This 2017 - 1 publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 – Mr. Christopher Klaczyk r age be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA's issuance of a substantial equivalented with other requirements of the Act that FDA has made a determination that your device complies with of the that FDA has made a determination that your device compire Frederal agencies. You must or any Federal statutes and regulations adminstered by other to: registration and lis or any Federal statutes and regulations administered by out its in the many institution and listing (21) comply with all the Act 3 requirements, including, but not limited to comply with all the Act srequirements, including, out not mines were as set CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set CFR Part 807); labeling (21 CFR Part 801); good manufacturing practices lequences and secondent of the electronic forth in the quality systems (QS) regulation (21 CFR Part 82 forth in the quality systems (QS) regulation (2) CFA of the Act); 21 CFR 1000-1050. product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation control provisions (Sections 33 - 3-2 of the Roy) = 1 This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will allow you to begin marketing your device of your device of your device to a legally premarket notification. The FDA inches if section for your device and th premarket notification. The FDA finding of substantial equivalies or your device marketed predicate device results in a classification for your device and thus, permits your to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please r in the supportunities and 10 10 - Also, please note the regulation entitl If you desire specific advice for your device on but nating bease note the regulation entitled, contact the Office of Compliance at (240) 276-0120. Also, play obtain. contact the Office of Compliance at (240) 2/05/2017 (21CFR Part 807.97) you may obtain. "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may bolta "Misbranding by reference to premarket notification" (2) Act may be obtained from the Other general information on your responsibilities under the Act may be obtained from th Other general information on your responsional and Consumer Assistance at its toll-free number Division of Small Manufacturers, International and Consumer Assistance at its t Division of Sinal Manufact.rers, or at its Internet address (600) 056-2011 01 \/cdrh/dsma/dsmamain.html Sincerely yours, Bhummoe for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## WelchAllyn Abbreviated 510(k) Premarket Notification Welch Allyn Printing Electrocardiography and Spirometry Products ## 11. Statement of Indications For Use 510(k) Number (if known): Device Name: CP100 and CP200 K050074 Indications For Use: The Welch Allyn Printing Electrocardiography and Spirometry Products (Subject Devices) are intended for use by trained operators in health facilities. The subject Devices will provide the following diagnostic functions: - Acquiring, viewing, storing and printing ECG waveforms patients using ECG � Front End modules and associated accessories that provide signal acquisition for Front End modules and associated accessories through surface electrodes adhered to the body. - Using optional algorithms to generate measurements, data presentations, graphical . presentations and interpretive statements on an advisory basis for patients of presentations and interpreive satences on above. These are presented for review and sixteen (10) years of age and as ven knowledge of the patient, the results of the prelation by the comreter. ECG tracings, and other clinical findings. - Using the optional Spirometry module and associated accessories to acquire, . Using the optional Spiromea's and waveforms of pulmonary function including, view, store and print measures and flow of air that can be moved in and out of a patient's lungs. These measures are used in the diagnosis and monitoring of of a patient's lungs. These modeles for the treatment of certain lung diseases. The lung diseases and menventions for are able to understand the instructions Spirometer may be used with pations that are and interpretive results are not calculated for children under the age of six. Prescription Use __ X (Part 21 CFR 801 Subpart D) Over-The-Counter Use (Part 21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) and/or Blimmerman (Division Sign-Off) Division of Cardiovascular Devices Page 1 of 1 MPD FCD-0025, Rev. 1 510(k) Number Section 11 - Page 1 of 1 This document contains information considered to be CONFIDENTIAL to Welch Allyn, Inc.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%